# PREGABALIN
> **ANDA212988** · Abbreviated New Drug Application (Generic) · Sponsor: ESKAYEF · Approved 2022-03-08
## Drug
- **FDA Application Number:** ANDA212988
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PREGABALIN
- **Generic name:** PREGABALIN
- **Active ingredients:** PREGABALIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ESKAYEF
- **Manufacturer:** Eskayef Pharmaceuticals Limited
- **First approval:** 2022-03-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212988)
---
*AI Analytics · CC0 1.0*